¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ÀǾàǰº°, Åõ¿© °æ·Îº°, ÃÖÁ¾ ¿ëµµº°, ¿ëµµº°, ±¹°¡º°, ºÎ¹® ¿¹Ãø(2025-2030³â)
U.S. General Anesthesia Drugs Market Size, Share & Trends Analysis Report By Drug, By Route Of Administration, By End-use, By Application, By Country, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1654141
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 70 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀåÀǼºÀå°ú µ¿Çâ :

Grand View Research, Inc.¿¡ µû¸£¸é ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 20¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 2.82%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¼ºÀåÀ» °ßÀÎÇÏ´Â °ÍÀº ÁÖ·Î ¼ö¼ú °Ç¼ö Áõ°¡ÀÔ´Ï´Ù. ¹Ì±¹ ¸¶Ãë°úÇÐȸ(ASA)´Â Àα¸ °í·ÉÈ­, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ¼ö¼ú±â¼ú Áøº¸·Î ÀÎÇÑ ¼ö¼úÀÇ ÀϰüµÈ Áõ°¡¸¦ °­Á¶ÇÕ´Ï´Ù. CDC´Â 2024³â 2¿ù¿¡ ¾à 1¾ï 2,900¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ¾Ï, ½ÉÀ庴, ´ç´¢º´, °íÇ÷¾Ð µî ÁÖ¿ä ¸¸¼º ÁúȯÀ» Àû¾îµµ Çϳª °¡Áö°í ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ ³ô±â ¶§¹®¿¡ ½ÉÀåÇ÷°ü ¹× ±âŸ ¼ö¼úÀÌ ¸¹ÀÌ ÇÊ¿äÇϸç, ±× °á°ú È¿°úÀûÀÎ Àü½Å ¸¶ÃëÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

¸¶Ãë ±â¼úÀÇ Áøº¸µµ Áß¿äÇÑ ÃËÁø¿äÀÎÀÔ´Ï´Ù. ·¹¹ÌÆæÅ¸´Ò°ú °°Àº Ãʴܽð£ ÀÛ¿ë ¸¶ÃëÁ¦¿Í °°Àº ±â¼ú Çõ½ÅÀº ¸¶Ãë ½Éµµ Á¶ÀýÀ» °³¼±Çϰí ȸº¹ ½Ã°£À» ´ÜÃà½ÃÄÑ È¯ÀÚ °á°ú¸¦ Çâ»ó½ÃŰ°í ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. ¶ÇÇÑ ÀÚµ¿ ¸¶Ãë Àü´Þ ½Ã½ºÅÛÀ» Æ÷ÇÔÇÑ °í±Þ Àü´Þ ½Ã½ºÅÛ ¹× ¸ð´ÏÅ͸µ ±â¼úÀÇ °³¹ßÀº Á¤È®¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃÄÑ ¸¶Ãë Áø·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù.

±ÔÁ¦ °³¹ßµµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. FDAÀÇ È¹±âÀûÀÎ Ä¡·áÁ¦¿¡ ´ëÇÑ ½Å¼Ó ½ÂÀÎ ÆÐ½º¿þÀÌ´Â »õ·Ó°í È¿°úÀûÀÎ ¸¶ÃëÁ¦¿¡ ´ëÇÑ ½Å¼ÓÇÑ Á¢±ÙÀ» ÃËÁøÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, »õ·Î¿î ¼­¹æÇü ¸¶ÃëÁ¦ÀÎ ZYNRELEFTMÀÇ ÃÖ±Ù ½ÂÀÎÀº ±ÔÁ¦ÀÇ ¹ßÀüÀÌ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ µµÀÔÀ» Áö¿øÇÏ´Â ¹æ¹ýÀ» º¸¿©ÁÝ´Ï´Ù.

¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå º¸°í¼­ ¹× ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ÀǾàǰ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : Åõ¿© °æ·ÎÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¹Ì±¹ÀÇ Àü½Å ¸¶ÃëÁ¦ ½ÃÀå : ÀǾàǰ, Åõ¿© °æ·Î, ÃÖÁ¾ ¿ëµµ ¹× ¿ëµµº° Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. General Anesthesia Drugs Market Growth & Trends:

The U.S. general anesthesia drugs market size is projected to reach USD 2.03 billion by 2030, and is anticipated to grow at a CAGR of 2.82% from 2025 to 2030, according to Grand View Research, Inc. The rising number of surgical procedures primarily drives this growth. The American Society of Anesthesiologists (ASA) highlights a consistent increase in surgeries, attributed to an aging population, the growing prevalence of chronic diseases, and advancements in surgical techniques. The CDC reported in February 2024 that approximately 129 million Americans have at least one major chronic disease, such as cancer, heart disease, diabetes, and hypertension. This high prevalence of chronic conditions necessitates numerous cardiovascular and other surgeries, which in turn drives the demand for effective general anesthesia drugs.

Advancements in anesthesia technology are another critical driver. Innovations such as ultra-short-acting anesthetics, like remifentanil, offer improved control over anesthesia depth and faster recovery times, enhancing patient outcomes and driving market growth. Additionally, the development of advanced delivery systems and monitoring technologies, including automated anesthesia delivery systems, has revolutionized anesthesia practices by improving precision and safety.

Regulatory developments also play a significant role. The FDA's expedited approval pathways for breakthrough therapies facilitate quicker access to new and effective anesthetics. For instance, the recent approval of ZYNRELEFTM, a novel extended-release anesthetic, illustrates how regulatory advancements support the introduction of innovative products.

U.S. General Anesthesia Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. General Anesthesia Drugs Market Variables, Trends & Scope

Chapter 4. U.S. General Anesthesia Drugs Market: Drug Estimates & Trend Analysis

Chapter 5. U.S. General Anesthesia Drugs Market: Route of Administration Estimates & Trend Analysis

Chapter 6. U.S. General Anesthesia Drugs Market: End Use Estimates & Trend Analysis

Chapter 7. U.S. General Anesthesia Drugs Market: Application Estimates & Trend Analysis

Chapter 8. U.S. General Anesthesia Drugs Market: Regional Estimates & Trend Analysis by Drug, Route of Administration, End Use and Application

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â